Featured Post

Latest Gold News

Economic power could shift further East with Hong Kong gold exchange Russian investment bank sees $1,400 gold by end of 2017 Weak CPI...

Tuesday, January 3, 2012

Mindray (MR) (ALXN) (HOME) (FTEK) (AKAM) (KEX) Ratings, Price Targets

Mindray Medical International Limited (NYSE: MR), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), Home Federal Bancorp Inc. (NASDAQ: HOME), Fuel Tech Inc. (NASDAQ: FTEK), Akamai Technologies (NASDAQ: AKAM) and Kirby Co. (NYSE: KEX) ratings and price targets.

Mindray Medical International Limited (MR) is now covered by Barclays Capital (NYSE:BCS). They have an “equal weight” rating on the firm.

Alexion Pharmaceuticals, Inc. (ALXN) had its price target raised by Bank of America (NYSE:BAC) to $82.00.

Home Federal Bancorp Inc. (HOME) was downgraded by Zacks Investment Research from an “outperform” rating to a “neutral” rating.

Fuel Tech Inc. (FTEK) was downgraded by Avondale Partners from an “outperform” rating to a “market perform” rating.

Akamai Technologies (AKAM) was downgraded by Janney Montgomery Scott from a “buy” rating to a “neutral” rating.

Kirby Co. (KEX) was upgraded by RBC Capital from an “outperform” rating to an “outperform” rating. They have a price target of $80.00 on the firm, up from $74.00.

No comments: